288 related articles for article (PubMed ID: 23024635)
1. An emerging role for adenosine and its receptors in bone homeostasis.
Ham J; Evans BA
Front Endocrinol (Lausanne); 2012; 3():113. PubMed ID: 23024635
[TBL] [Abstract][Full Text] [Related]
2. P2 receptors in bone--modulation of osteoclast formation and activity via P2X7 activation.
Gartland A; Buckley KA; Hipskind RA; Bowler WB; Gallagher JA
Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):237-42. PubMed ID: 14696970
[TBL] [Abstract][Full Text] [Related]
3. The roles of adenosine and adenosine receptors in bone remodeling.
He W; Cronstein B
Front Biosci (Elite Ed); 2011 Jun; 3(3):888-95. PubMed ID: 21622100
[TBL] [Abstract][Full Text] [Related]
4. Extracellular purines and bone homeostasis.
Agrawal A; Jørgensen NR
Biochem Pharmacol; 2021 May; 187():114425. PubMed ID: 33482152
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of adenosine on the function of rodent osteoblasts and osteoclasts in vitro.
Hajjawi MO; Patel JJ; Corcelli M; Arnett TR; Orriss IR
Purinergic Signal; 2016 Jun; 12(2):247-58. PubMed ID: 26861849
[TBL] [Abstract][Full Text] [Related]
6. Purinergic signalling in osteoblasts.
Gartland A; Orriss IR; Rumney RM; Bond AP; Arnett T; Gallagher JA
Front Biosci (Landmark Ed); 2012 Jan; 17(1):16-29. PubMed ID: 22201729
[TBL] [Abstract][Full Text] [Related]
7. Control of bone development by P2X and P2Y receptors expressed in mesenchymal and hematopoietic cells.
Lenertz LY; Baughman CJ; Waldschmidt NV; Thaler R; van Wijnen AJ
Gene; 2015 Oct; 570(1):1-7. PubMed ID: 26079571
[TBL] [Abstract][Full Text] [Related]
8. Adenosine and bone metabolism.
Mediero A; Cronstein BN
Trends Endocrinol Metab; 2013 Jun; 24(6):290-300. PubMed ID: 23499155
[TBL] [Abstract][Full Text] [Related]
9. Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors.
Jørgensen NR; Henriksen Z; Sørensen OH; Eriksen EF; Civitelli R; Steinberg TH
J Biol Chem; 2002 Mar; 277(9):7574-80. PubMed ID: 11756404
[TBL] [Abstract][Full Text] [Related]
10. Purinergic Signaling and Aminoglycoside Ototoxicity: The Opposing Roles of P1 (Adenosine) and P2 (ATP) Receptors on Cochlear Hair Cell Survival.
Lin SCY; Thorne PR; Housley GD; Vlajkovic SM
Front Cell Neurosci; 2019; 13():207. PubMed ID: 31156393
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
Neary JT; McCarthy M; Kang Y; Zuniga S
Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
[TBL] [Abstract][Full Text] [Related]
12. Purinergic signaling in the pancreas and the therapeutic potential of ecto-nucleotidases in diabetes.
Cieślak M; Roszek K
Acta Biochim Pol; 2014; 61(4):655-62. PubMed ID: 25522227
[TBL] [Abstract][Full Text] [Related]
13. Purinergic Receptors in Adipose Tissue As Potential Targets in Metabolic Disorders.
Tozzi M; Novak I
Front Pharmacol; 2017; 8():878. PubMed ID: 29249968
[TBL] [Abstract][Full Text] [Related]
14. Purinergic Regulation of Neutrophil Function.
Wang X; Chen D
Front Immunol; 2018; 9():399. PubMed ID: 29545806
[TBL] [Abstract][Full Text] [Related]
15. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
16. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin.
Evans BA; Elford C; Pexa A; Francis K; Hughes AC; Deussen A; Ham J
J Bone Miner Res; 2006 Feb; 21(2):228-36. PubMed ID: 16418778
[TBL] [Abstract][Full Text] [Related]
17. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling.
Hoebertz A; Mahendran S; Burnstock G; Arnett TR
J Cell Biochem; 2002; 86(3):413-9. PubMed ID: 12210747
[TBL] [Abstract][Full Text] [Related]
18. Role of Purinergic Signaling in Acupuncture Therapeutics.
Lv ZY; Yang YQ; Yin LM
Am J Chin Med; 2021; 49(3):645-659. PubMed ID: 33641652
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Ca2+ signaling and glucagon secretion in mouse pancreatic alpha-cells by extracellular ATP and purinergic receptors.
Tudurí E; Filiputti E; Carneiro EM; Quesada I
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E952-60. PubMed ID: 18349114
[TBL] [Abstract][Full Text] [Related]
20. Purinergic signalling and bone remodelling.
Orriss IR; Burnstock G; Arnett TR
Curr Opin Pharmacol; 2010 Jun; 10(3):322-30. PubMed ID: 20189453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
